Coherus Oncology, Inc. Inventory
Coherus Oncology, Inc. (CHRS) had Inventory of $5.67 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-05
- 2026-06-30: Inventory, Net $5.67M.
- 2026-03-31: Inventory, Net $4.83M.
- 2025-12-31: Inventory, Net $3.17M.
- 2025-09-30: Inventory, Net $2.05M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $5.67M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.83M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $3.17M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $2.05M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.51M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.52M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $4.21M 10-K · filed 2026-03-09 | $70.09M 10-K · filed 2025-03-17 |
| 2024-09-30 | $47.64M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $62.16M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $61.98M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.09M 8-K · filed 2025-11-13 | $62.60M 10-K · filed 2024-03-15 |
| 2023-09-30 | $66.78M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $63.99M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $49.41M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $38.79M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $27.72M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $31.74M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $36.95M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $37.64M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $37.58M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $39.67M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $51.61M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $44.23M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $35.25M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $27.19M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $16.44M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $9.81M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $7.67M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $4.33M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $2.31M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.66M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |